Catherine Novack
Stock Analyst at Jones Trading
(0.42)
# 4,085
Out of 4,944 analysts
20
Total ratings
18.75%
Success rate
-20.19%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Novack
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DYN Dyne Therapeutics | Initiates: Buy | $30 | $11.64 | +157.84% | 1 | Jun 26, 2025 | |
| CAPR Capricor Therapeutics | Maintains: Buy | $40 → $29 | $8.04 | +260.70% | 2 | Jun 25, 2025 | |
| FEMY Femasys | Maintains: Buy | $10 → $6 | $0.73 | +721.92% | 2 | May 13, 2025 | |
| RLYB Rallybio | Downgrades: Hold | n/a | $0.50 | - | 1 | Apr 15, 2025 | |
| PVLA Palvella Therapeutics | Initiates: Buy | $45 | $43.11 | +4.40% | 1 | Mar 25, 2025 | |
| PRQR ProQR Therapeutics | Initiates: Buy | $11 | $1.91 | +475.92% | 1 | Feb 12, 2025 | |
| KRRO Korro Bio | Initiates: Buy | $130 | $15.99 | +713.01% | 1 | Nov 18, 2024 | |
| EQ Equillium | Downgrades: Hold | n/a | $0.93 | - | 1 | Nov 1, 2024 | |
| WVE Wave Life Sciences | Maintains: Buy | $12 → $16 | $8.45 | +89.35% | 2 | Sep 25, 2024 | |
| LRMR Larimar Therapeutics | Initiates: Buy | $14 | $3.70 | +278.38% | 1 | Sep 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $13 | $2.03 | +540.39% | 2 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $6.20 | +61.29% | 1 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $2.48 | +787.10% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $3.91 | - | 2 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $160 | $2.25 | +7,011.11% | 1 | Jul 21, 2023 |
Dyne Therapeutics
Jun 26, 2025
Initiates: Buy
Price Target: $30
Current: $11.64
Upside: +157.84%
Capricor Therapeutics
Jun 25, 2025
Maintains: Buy
Price Target: $40 → $29
Current: $8.04
Upside: +260.70%
Femasys
May 13, 2025
Maintains: Buy
Price Target: $10 → $6
Current: $0.73
Upside: +721.92%
Rallybio
Apr 15, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.50
Upside: -
Palvella Therapeutics
Mar 25, 2025
Initiates: Buy
Price Target: $45
Current: $43.11
Upside: +4.40%
ProQR Therapeutics
Feb 12, 2025
Initiates: Buy
Price Target: $11
Current: $1.91
Upside: +475.92%
Korro Bio
Nov 18, 2024
Initiates: Buy
Price Target: $130
Current: $15.99
Upside: +713.01%
Equillium
Nov 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.93
Upside: -
Wave Life Sciences
Sep 25, 2024
Maintains: Buy
Price Target: $12 → $16
Current: $8.45
Upside: +89.35%
Larimar Therapeutics
Sep 12, 2024
Initiates: Buy
Price Target: $14
Current: $3.70
Upside: +278.38%
Aug 16, 2024
Maintains: Buy
Price Target: $5 → $13
Current: $2.03
Upside: +540.39%
Apr 18, 2024
Initiates: Buy
Price Target: $10
Current: $6.20
Upside: +61.29%
Feb 16, 2024
Initiates: Buy
Price Target: $22
Current: $2.48
Upside: +787.10%
Oct 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $3.91
Upside: -
Jul 21, 2023
Initiates: Buy
Price Target: $160
Current: $2.25
Upside: +7,011.11%